3rd Quarter - Report
ARENTFOX SCHIFF LLP for ALLERGAN PLC
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 3187 (Food and Drug Administration Safety and Innovation Act) regarding drug supply, patient access, citizen petitions, and Risk Evaluation and Mitigation Strategies (entire bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY DEMSKE | — |
| PHILIP ENGLISH | — |
Medicare/Medicaid MMM
Medicare reimbursements for oncology drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY DEMSKE | — |
| PHILIP ENGLISH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.